Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

about

Acute stroke in patients on new direct oral anticoagulants: how to manage, how to treat?Successful intravenous thrombolysis following full dose rivaroxaban 5 hours before ictus.

P2860

Q38228428-C671569D-0105-443F-857D-8537F2458360 Q48240464-4864ED61-5042-46CE-8DBA-39421D4050E5

P2860

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

Item

http://www.wikidata.org/entity/Q42258033

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

@en

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

@nl

type

Item

label

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

@en

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

@nl

prefLabel

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

@en

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

@nl

P1476

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

@en

P2093

Christoph Kleinschnitz

http://www.w3.org/2001/XMLSchema#string

Felix Fluri

http://www.w3.org/2001/XMLSchema#string

Florian Heinen

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

Evidence-based stroke r-ehabilitation: an expanded guidance document from the european stroke organisation (ESO) guidelines for management of ischaemic stroke and transient ischaemic attack 2008.

Laboratory assessment of new anticoagulants.

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.

Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.

Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.

P304

153-155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000355839

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259354548

http://www.w3.org/2001/XMLSchema#string

P698

24348499

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis

P932

3843901

http://www.w3.org/2001/XMLSchema#string

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

about

P2860

P2860

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932